All posts by medical

funded effort may help people with intellectual disability participate in clinical studies – National Institutes of Health

Media Advisory

Monday, February 24, 2020

The NIH Toolbox Cognitive Battery an assessment of cognitive functioning for adults and children participating in neuroscience research c an be adapted to people with intellectual disabilities by modifying some test components and making accommodations for the test-takers disabilities, according to researchers funded by the National Institutes of Health. The adaptations ensure that the battery can be used to assess the cognitive ability of people with intellectual disabilities who have a mental age of 5 years and above, providing objective measures that could be used in a wide variety of studies.

The research team, led by David Hessl, Ph.D., of the University of California Davis Medical Center, published their findings in Neurology. The work was funded by NIHs Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and National Center for Advancing Translational Sciences, as well as the Administration for Community Living.

The battery is administered on a computer tablet and measures memory, vocabulary, reading and executive functioning, which includes skills such as the ability to shift from one thought to another, pay attention and control impulses. The researchers adapted the battery by reducing the complexity of the instructions and including developmentally appropriate starting points. They also developed a structured manual to guide test administrators.

The researchers validated the battery and its modifications by assessing 242 people ages 6 through 25 with fragile X syndrome, Down syndrome or other disabilities. They found that the battery produced reliable and valid results for those with a mental age of 5 years and above. The authors called for additional research to adapt the battery to people with lower mental ages and to older adults with intellectual disability who may be experiencing cognitive decline or dementia.

Alice Kau, Ph.D., of the NICHD Intellectual and Developmental Disabilities Branch is available for comment.

Shields, R et al. Validation of the NIH Toolbox Cognitive Battery in intellectual disability. Neurology. 2020. http://dx.doi.org/10.1212/WNL.0000000000009131.

About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NICHD leads research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. For more information, visit https://www.nichd.nih.gov.

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

Continue reading here:
funded effort may help people with intellectual disability participate in clinical studies - National Institutes of Health

Why We Fail To Reach Goals: Our Brains Begin With One Focus, But Closing The Deal Requires Another, Study Suggests – Forbes

Getty

All of us start out after a goal with energy and motivation, so why do we so often fail to hit the target? A new study at the intersection of neuroscience and behavioral science offers a simple but useful insight about the failure to reach goals. It centers on the disconnect between our decision-making focus before we start pursuing a goal and our focus after we begin.

The study started with this hypothesis:

Researchers then conducted two experiments designed to measure physical and mental effort in pursuit of rewards (in this case, financial rewards). In both experiments, participants were offered options for combining high or low effort with high or low financial rewards. Giving them the choice allowed participants to align their expectations (high effort for more reward, lower effort for less reward, etc.).

The results of the experiments were consistent for both physical and mental effort: the amount of the financial reward influenced how the participants chose their effort-reward combinations, as expected. But when they started the work, their performance was determined by how much effort reaching the reward was really going to require, regardless of how much money was at stake.

In other words, a focus on rewards fueled the pursuit, but a focus on effort took over when the work started.

We found that there isnt a direct relationship between the amount of reward that is at stake and the amount of effort people actually put in, said Dr. Agata Ludwiczak, lead study author and research fellow from Queen Mary University of London. This is because when we make choices about what effort to put in, we are motivated by the rewards we expect to get back. But at the point at which we come to actually do what we had said we would do, we focus on the level of effort we have to actually put in rather than the rewards we hoped we would get.

The problem, according to this study, is that we fail to refocus on the reward not just once, but as often as needed to keep effort in perspective as the means to our desired end.

An even more basic problem is not realistically thinking through the effort required to achieve a goal from the outset.

Then when we face the reality of our choices, we realize the effort is too much and give up, added Dr. Magda Osman, study co-author and professor in experimental psychology at Queen Mary University, in a press statement. For example, getting up early to exercise for a new healthy lifestyle might seem like a good choice, but once your alarm goes off on a cold January morning, the rewards arent enough to get you up and out of bed.

In fairness, though, we dont always have the best sense of how much effort something will require, especially if its a goal we havent pursued before. Getting better at making decisions has much to do with figuring this out and not letting ourselves forget the lesson.

These findings backup those from previous neuroscience and behavioral science studies that tell us about the disconnect between our brains valuation of rewards and the get it done realities that influence our behavior. Our brains are reward-driven organs supercharged by neurotransmitters that fuel our drives and desires, especially dopamine, and its easy for us to get carried away in this chemical tsunami. It happens to us all the time, whether were thinking about it or not, even when we have plenty of experience to guide us.

The takeaway from this research has two parts. First, we must begin our goal pursuits with as much realistic acknowledgement of the effort required as possible, no matter how strongly the chemical surge hits us. Then, once we begin, we must refocus back to the reward and keep the effort in perspective.

That will at least give us a fighting chance of reaching the goal, recognizing, of course, any number of other factors can still change the game.

The study was published in the journal Behavioral Brain Research.

Read more from the original source:
Why We Fail To Reach Goals: Our Brains Begin With One Focus, But Closing The Deal Requires Another, Study Suggests - Forbes

A deeper look into the mind of a criminal: using brain scans for insanity defense – WJBF-TV

In this day oftechnology, lawyers and doctors are attempting to use brain scan to look intothe mind of criminals. Think MRIs, think PET scans that look at peoples brainsand try to figure out why they commit crimes. Is that useful? Is that somethingthat we could depend on in a trial? Well talk about it. Speaking of trials,how about neurolaw? It is really making headlines lately and it has to do withtrying to use the discoveries of neuroscience and try to apply them in a legalsetting. Well talk about how useful neurolaw is and if its something thatcould continue to make headway in the future. And internet-based data, whatdoes that mean? That means what if somebody posts something that is somewhatsketchy and then later they become the next mass shooter. Should we have seenthose red flags in those social media posts? We cant think of a better personto tackle all of those difficult subjects with than MCG Forensic Psychologist,Dr. Michael Vitacco, a Means Report veteran.

Brad Means: Dr.Vitacco, thanks as always for coming back.

Dr. Michael Vitacco:Thanks for having me.

Brad Means: Well,lets take a look at this imaging that I talked about. That was the firstbullet point we saw on our screen.

Dr. Michael Vitacco:Yes, sir.

Brad Means: Is itpossible to take a photograph of someones brain and see if they are going tobe a criminal or to see what made them commit a crime?

Dr. Michael Vitacco:Yeah, thats a really emerging topic within the idea of neuroscience.

Brad Means: Yeah.

Dr. Michael Vitacco:And what has been going on is that some of these applications have been used inexactly that manner. The problem with this is that many of them are being usedincorrectly. And people are using images to make these sort of assertions youjust spoke about, like hey, this helps us understand this or this leads tothis, when in fact, the science is not quite there yet. So a lot of thesetopics are actually, and these technologies are being misused. And thatswhere, as a scientist and a forensic psychologist, we want to kind of put thebrakes on some of these things and make sure were using it appropriately andcorrectly in scientifically backed manners.

Brad Means: Forpeople who support this, do they look for plaque or irregularities in the humanbrain and say, ah, there you see, criminal.

Dr. Michael Vitacco:Thats exactly what they do. They look for primarily irregularities ordifferent things, but the problem there with that is those irregularities arepresent in many people, including many people who never commit a crime. Andbecause of that, just because an individual has a specific or atypical brainissue, it ultimately tells you very, very little. And it tells you almost nothingabout their motive or different things like that which, when we get to the whyis one of the most critical things we can think of.

Brad Means: Is itstill too early in this, or are we already seeing things like this beadmissible in court, a PET scan image, an MRI image, where the judge isaccepting it into evidence?

Dr. Michael Vitacco:Well, thats exactly a huge point. Its being accepted often without the judgeor the trier of fact giving it appropriate vetting. So often, its beingadmitted, and sometimes its being admitted wrongly.

Brad Means: So isit fair to say that what weve been talking about so far falls under thisneurolaw umbrella?

Dr. Michael Vitacco:Yeah, neurolaws exactly kind of the name for it. Its a subtype ofneuroscience, where neuroscience is being specifically applied to legal issues.And so neurolaw, and theres centers all over the country. So theyre trying tomake strides in this way, but unfortunately, in many applications, it is beingmisused.

Brad Means: Itseems like there would be a substantial amount of money to be made in thisfield.

Dr. Michael Vitacco:There is absolutely a substantial lot of money and theres also backing fromdonors who want to get their scans or their particular equipment into this areabecause in civil lawsuits or various things, it can become quite lucrative. AndI think thats fine, Im not speaking anything directly against that, but weneed to make sure that we have the appropriate scientific backing before weengage in these types of leaps when we talk about what the brain images showand what they actually mean regarding human behavior.

Brad Means: Whatwill it take to get there, more trials, years and years of research?

Dr. Michael Vitacco:Thats exactly right. We need to have years and years of research. We need tohave strongly regulated scientific studies, like anything, and we need to thenshow, in replication, where we kind of repeat whats been done, that thesestudies are actually showing us what they are.

Brad Means: Wevetalked before about the insanity defense.

Dr. Michael Vitacco:Yes.

Brad Means: Andso I wanna talk about that and regardless of what an imaging machine shows, howyou could determine if someone is insane. Whats the definition of insanity?

Dr. Michael Vitacco:Right, so insanity is, the kind of colloquial definition is where you have amental illness, a serious and severe mental illness and because of that illnessyou dont understand right from wrong at the time.

Brad Means: Okay.

Dr. Michael Vitacco:So thats kind of what all states tend to use.

Brad Means: Themental illness component has to be present.

Dr. Michael Vitacco:Has to be present first and then, that it leads to someone not understandingright from wrong.

Brad Means: Okay,so you cant have one without the other. In other words, you know, every childunder the age of three is not insane.

Dr. Michael Vitacco:No.

Brad Means: Theydont know right or wrong.

Dr. Michael Vitacco:But they dont know right from wrong.

Brad Means: Butyou have to have the mental illness there.

Dr. Michael Vitacco:Right.

Brad Means: Allright, so how do you go about concluding that before youre called as an expertwitness to say, look my recommendation is that you consider this person insane.

Dr. Michael Vitacco:Well, and it happens very rarely, but what we try to do is look at totalevidence thats available. And really also it kind of gets into motives. Wewant to know if someone is mentally ill, why did they do what they did? Forexample, someone can have a mental illness, get angry at someone and act out.And thats not insane, thats just someone whos angry versus someone who has amental illness maybe thinks someone is after them and because of that mentalillness and then acts against that. And thats more of a prototypical, regulardefinition of what insanity looks like.

Brad Means: Sowhen you get involved in those forensic psychological interviews take place inyour office or in the jail cell, are you looking for someone who, are youlooking to determine is someone has been insane their entire lives or iftheyre just insane at the time of the offense?

Dr. Michael Vitacco:Well it only matters really at the time at the offense.

Brad Means: Thatsall youre concerned about. Thats all they want you to look at.

Dr. Michael Vitacco:Yes.

Brad Means: Andyou said more times than not, you dont recommend insanity.

Dr. Michael Vitacco:By far, by probably 95, 90% of the time we dont recommend insanity.

Brad Means: Why,most people arent insane?

Dr. Michael Vitacco:Most people are not insane. Most people when they do something, even if itsnot understandable, even if its heinous, even if we cant understand it, theystill understood that what they were doing was against the law and against themorals of society.

Brad Means: Howquickly can you tell if someone is trying to dupe you and what do you look for?

Dr. Michael Vitacco:Well, you look for patterns of behavior over the course of time. So if there isa history of such things its very evident. Its very hard to have a longstanding mental illness and it never shows up anywhere.

Brad Means: Right.

Dr. Michael Vitacco:Theres always some kind of evidence that that is apparent.

Brad Means: Determiningif someone can tell right from wrong seems like a huge, daunting task.

Dr. Michael Vitacco:It can be.

Brad Means: Evenif the mental illness is there. So lets say youve got that part checked offand now youre going to the, do you know right from wrong part. Other than themtelling you that they dont know right from wrong, how do you determine that? Abunch of questions?

Dr. Michael Vitacco:A bunch of questions and then often what we do, I mean, many more times thannot is we talk to people who saw the crime. And now days we often get just aton of video evidence. Its almost hard to walk anywhere or go anywhere nowwhere theres not video evidence of where you are, cell phone evidence and justa variety of things. And we take all that together and we sort of disentangleit to try to get as close of a picture as possible of this persons behaviorand then the ultimate motives for such a behavior.

Brad Means: Is itpossible in the course of this brief interview together for you to kind of showme what it looks like and say look, heres one time when I determined that thisperson was insane because they said this to me. Or there was a moment in theinterview when I thought, okay this is officially an insane person.

Dr. Michael Vitacco:Yeah theres never one moment. Its usually a, several moments kind of puttogether. So and often like you kow, were going to talk to people around themso, how were acting the day it happened? How were they acting before thathappened? Were they calm, were they agitated? And you collect all this data andthat really helps inform our opinions of someones actual mental state at thetime of the offense.

Brad Means: Wetalked earlier about these images, that neuroalaw outlets are using.

Dr. Michael Vitacco:Yeah, right.

Brad Means: Andtheyre becoming more and more popular. I know youre among the naysayers. Butdoes a criminals brain look different in some cases than others? Ive heardthat pedophiles might have tumors

Dr. Michael Vitacco:Sure.

Brad Means: andthats a way to know that they are a pedophile or might become one. Does thecriminal brain sometimes actually look different?

Dr. Michael Vitacco:So we actually just published a paper in neuroethics on this topic of insanitydefense and neurolaw. And there has been some evidence where, for example,there as a case where a teacher started having sexual urges towards a child.And through the course of a bunch of evaluations, they actually found a tumorpressing on it, and when that was removed, he kind of went back to not havingthese urges. Whats really important to note about that is that even while thistumor was present he was taking major steps to hide his behavior, to concealinappropriate actions, to avoid his wife, and to hide some of these thoughts hewas having. When somebodys going through such pains to hide their behavior,that they know is illegal, that really suggests that they, despite the factthat they were having a hard time stopping themselves that they understood whatthey were doing was wrong. So even the fact that that tumor was present, stilldid not indicate that he did not understand the difference between right andwrong.

Brad Means: Sure,that behavior might have been there anyway.

Dr. Michael Vitacco:It could have been. But the mere fact that they were taking such steps to hideit and going through very elaborate processes was very informative. And even aswe talked about the specific case, provided real thorough evidence despite thefact that there was a brain issue, that the individual still understood rightfrom wrong. And thats one of the primary limitations of neurolaw is it doesntget at that motive and that ability to sort of get at the ultimate behaviorthat speaks to the issue.

Brad Means: Whenwe come back, were going to talk about some cases that have been in the newslately and why certain criminals may have behaved the way they did. As wecontinue our discussion with forensic psychologist, Dr. Michael Vitacco on TheMeans Report.

Part 2

Brad Means: Welcomeback to The Means Report. We appreciate your staying with us as we continue togo into the mind of a criminal, delve deeply into the mind of a criminal. Wecovered insanity and what it takes to make that determination in our firstsegment. And what good are brain images when it comes to looking at the mind ofa criminal. Dr. Michael Vitacco, forensic psychologist from Augusta Universitystill with us. Sometimes when youre watching those CSI type shows on TV youllsee criminal being interviewed, interrogated.

Dr. Michael Vitacco:Right.

Brad Means: Andyoull see on the screen an image of their brain and the interviewer is tryingto see how those brain waves react or respond to certain images or questions.Is that realistic?

Dr. Michael Vitacco:Its somewhat realistic.

Brad Means: Yeah.

Dr. Michael Vitacco:But the behavior that can be gleaned from that and the overall insights of thatbehavior based on those brain waves is still very, very limited. So you know,some of these brain imaging tools they have have also now been used as liedetectors and things. And again different areas of your brain will activate.But even some of that information has been called into serious question.

Brad Means: Areyou a lie detector fan?

Dr. Michael Vitacco:We dont use it in our practice.

Brad Means: Yeah.

Dr. Michael Vitacco:No, but even so, in fact its often not even admissible in criminal trials soagain those are things where we have to really improve our science before westart relying on such information especially when were talking about someonesfreedom. You know, these are high stakes sometimes.

Brad Means: Idont want to burst anybodys bubble, especially Marlena Wilson, our executiveproducer and director who loves CSI type shows. But I bet you sit there andshake your head a lot and say, thats not really how it works.

Dr. Michael Vitacco:That happens all the time.

Brad Means: Itdoes.

Dr. Michael Vitacco:And especially to where you know we see all these things being happen within ina very small period of time. You know we have evidence, convictions, trials,and its all done in 45 minutes plus commercials. Thats just not how lifeworks. Often these things go on for years.

Brad Means: Whatsthe difference between a sociopath and a psychopath?

Dr. Michael Vitacco:Thats the same sort of thing is that sociopath is an older term. It really meanssomeone who is antisocial and sort of lacks the ability and doesnt truly care.They lack emotions.

Brad Means: Okay.

Dr. Michael Vitacco:Especially regarding other people.

Brad Means: Isthat a form of mental illness?

Dr. Michael Vitacco:No, not by a legal definition.

Brad Means: Notby a legal definition.

Dr. Michael Vitacco:Right, being a psychopath does not excuse you from criminal behavior.

Brad Means: Weveseen a couple of cases in the news recently. We saw just this past week beforethe recording of this Means Report a tragic case out of South Carolina, asix-year-old girl

Dr. Michael Vitacco:I saw that.

Brad Means: whosebody was found. A mans body was found next to her, a 30-year-old man. Thepresumption is that he killed her and then killed himself.

Dr. Michael Vitacco:Thats right.

Brad Means: Takeme through the killing yourself part of things. What would be the benefit orgoal of a criminal, and were not convicting him. Were just using this as anexample because the case is in its early stages. of committing a heinous actagainst a child and then killing yourself never to be able to do that again. Whatsthat mindset and might that person have been determined insane one day?

Dr. Michael Vitacco:Yeah, so let me give, caveat this. I only know this from the news. Ive notinterviewed anyone so these are very speculative answers.

Brad Means: Absolutely,and my question too, I think I just told you all I know about it.

Dr. Michael Vitacco:Right so I dont know this particular case or what motivated him. I mean itspossible he felt tremendous guilt and he did it. Its also possible he didntwant to get caught and realized that his life was practically over anyway.Theres again several motives that could have come from that behavior. And itwould take a much deeper dive into his psychology and where his head was atwhich could be done if it was needed. But I think, safe to say, there was somesignificant problems with that individual.

Brad Means: Wesaw Dylann Roof in the headlines a few years ago out of Charleston, the massshooting at a church in Charleston, South Carolina, killed nine people.

Dr. Michael Vitacco:Thats right.

Brad Means: Hehad some disturbing social media posts.

Dr. Michael Vitacco:He did.

Brad Means: Andso that brings me to my next topic which is can social media posts be redflags, and how would you know when they cross the line between just an angryperson and a criminal?

Dr. Michael Vitacco:Well more and more now days in my field and across the board is were gettingsocial media posts, instant messages as part of our discovery packet. When youconsider over 70% of Americans engage in some sort of social media use, Icertainly do, I assume you might have a Facebook page.

Brad Means: I do,yeah.

Continue reading here:
A deeper look into the mind of a criminal: using brain scans for insanity defense - WJBF-TV

Submission: The Colonization of Academia of Colors’ Intellect – The UCSD Guardian Online

Guest writer Genie P. Wungsukit discusses the implicit effects of colonialism in academia and how it appears at UC San Diego.

People of color history and cultures are critically approached through the white perspectives and retold or, as the university calls it, taught through the white narratives. We are to be discovered, studied, and research by white academia.

White academia are the knowers, the authority, while the knowledge of different cultures is to be known, to be discovered. White academia and white institution are the academics, and every other culture and people of color intellects are to be studied. By the word studied, I mean approached by the white lens and picked apart through the white westerner norms.

The colonization of intellects appears everywhere in academia but is even more prominent in areas of study such as history which are heavily biased.

I came into the University of California, San Diego, as an undergraduate in Behavioural Neuroscience with a passion for reading and history. I have always been passionate about history because I genuinely believe we can only create a better future once we learned from our past mistakes.

I am a woman, an Asian woman. More specifically, I am half-Thai and half-Chinese. My grandparents were immigrants from China to Thailand. I was born in Thailand, where I spent most of my life until I moved to Oakland, California for high school. I am a first-generation immigrant to the United States. I am a first-generation college student. I am from a low socioeconomic background. I am a person of color. It is quite safe to say I dont have many privileges going for me, yet throughout my life, it has always been my dream to pursue higher education because I truly believe in the power of knowledge. I believe in intellectualism and curiosity. I believed that academia was a place I can learn, be curious, and ask questions.

I enrolled in a class titled East Asia & The West: 1279-1911. A 10 weeks course, covering 632 years of history in China, Japan, and Korea. The textbook was written by 3 white women, taught by an endowed, white men professor who graduated from Harvard and taught at Oxford (Two very traditionally old, white, and wealthy institutions) with the teaching assistant who also happens to be a white man.

When people of color histories are studied only through the white lens and further research in academia only cites the white intellects, disregarding the primary source, the authority, and diversity of that culture; we are yet again colonized. But this time, it is our intellects that are colonized.

I am in no way saying that a white person is not allowed to have an interest or pursue a study of another culture, but they should not be given the authority to tell the narrative of another culture. Anyone could be an expert on a subject they so choose to study, and I will not doubt their knowledge with the credentials, but they should not be allowed to colonized people of color intellects and retold our history as if their own. White academia should not be the default of academics in the age where we preach diversity in higher education.

How can I, as an Asian woman scholar, sit in a lecture hall, and listen to a white man talk about my history like he owns it?

The exclusivity and unacknowledged embedded institutional racism, which are deeply rooted in academic culture have made me skeptical of the value we give higher education.

As the next generation of scholars and a woman of color who wishes to pursue a career in academia, I still hope that we will put in the effort to decolonize intellects. I hope we diversify higher institutions. Hire more qualified academia of color, publish more academia of color, cite more academia of colour, tenure more academia of color, and honor the intellect that academia of color has at the same level of any white academia.

To the white academia, I hope that you will be able to recognize that you are not the authority figure of history and academics. I hope that you will know you do not own our history and our narrative. I hope that you will be able to realize that and step down for academia of color. I hope that you acknowledge that we all need to start decolonizing the intellects.

It could be naivet, or it could be the hopeless optimism I still have in humanity, but I still believe that we can decolonize the intellects in every field of study. I hope this piece of writing can be the starting point to a larger conversation in how the narratives being used by predominantly white educational institutions are perpetuating the hegemonic white default of humanity.

Genie P. Wungsukit is a Cognitive and Behavioural Neuroscience undergraduate minoring in Ethnic Studies with the focus on Asian American Studies at the University of California, San Diego.

Graphic Courtesy of the Benicial Historical Museum

Link:
Submission: The Colonization of Academia of Colors' Intellect - The UCSD Guardian Online

Video: From Brains to Agents and Back – insideHPC

Jane Wang from DeepMind

In this video fromNeurIPS 2019, Jane Wang from DeepMind Alberta presents: From Brains to Agents and Back.

Building on the connection between biological and artificial reinforcement learning, our workshop will bring together leading and emergent researchers from Neuroscience, Psychology and Machine Learning to share: how neural and cognitive mechanisms can provide insights to tackle challenges in RL research and how machine learning advances can help further our understanding of the brain and behavior.

Jane Wang is a research scientist at DeepMind. Her background is in computational and cognitive neuroscience, complex systems, and physics. She is interested in applying neuroscience principles to inspire new algorithms for artificial intelligence and machine learning.

See more talks from NeurIPS

Check out our insideHPC Events Calendar

Read this article:
Video: From Brains to Agents and Back - insideHPC

Brain waves show who’ll respond to Zoloft – Futurity: Research News

Share this Article

You are free to share this article under the Attribution 4.0 International license.

A new method for interpreting brain waves could potentially help determine the best depression treatment, according to a new study.

The researchers used electroencephalography, a tool for monitoring electrical activity in the brain, and an algorithm to identify a brain-wave signature in individuals with depression who will most likely respond to sertraline, an antidepressant marketed as Zoloft.

The study emerged from a decades-long effort to create biologically based approaches, such as blood tests and brain imaging, to help personalize the treatment of depression and other mental disorders. Currently, there are no such tests to objectively diagnose depression or guide its treatment.

This study takes previous research showing that we can predict who benefits from an antidepressant and actually brings it to the point of practical utility, says Amit Etkin, professor of psychiatry and behavioral sciences at Stanford University. I will be surprised if this isnt used by clinicians within the next five years.

Instead of functional magnetic resonance imaging, an expensive technology often used in studies to image brain activity, the scientists turned to electroencephalography, or EEG, a much less costly technology.

The paper is one of several based on data from a federally funded depression study launched in 2011the largest randomized, placebo-controlled clinical trial on antidepressants ever conducted with brain imagingwhich tested the use of sertraline in 309 medication-free patients.

The trial was called Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care, or EMBARC. The researchers designed the trial to advance the goal of improving the trial-and-error method of treating depression that is still in use today.

It often takes many steps for a patient with depression to get better, says co-senior author Madhukar Trivedi, professor of psychiatry at the University of Texas-Southwestern who led the research team.

We went into this thinking, Wouldnt it be better to identify at the beginning of treatment which treatments would be best for which patients?'

Major depression is the most common mental disorder in the United States, affecting about 7% of adults in 2017, according to the National Institute of Mental Health (NIMH). Among those, about half never get diagnosed.

For those who do, finding the right treatment can take years, Trivedi says. He points to one of his past studies that showed only about 30% of patients with depression saw any remission of symptoms after their first treatment with an antidepressant.

Current methods for diagnosing depression are simply too subjective and imprecise to guide clinicians in quickly identifying the right treatment, Etkin says. In addition to a variety of antidepressants, there are several other types of treatments for depression, including psychotherapy and brain stimulation, but figuring out which treatment will work for which patients is based on educated guessing.

To diagnose depression, clinicians rely on a patient reporting at least 5 of 9 common symptoms of the disease. The list includes symptoms such as feelings of sadness or hopelessness, self-doubt, sleep disturbancesranging from insomnia to sleeping too muchlow energy, unexplained body aches, fatigue, and changes in appetite, ranging from overeating to undereating. Patients often vary in both the severity and types of symptoms they experience, Etkin says.

As a psychiatrist, I know these patients differ a lot, Etkin says. But we put them all under the same umbrella, and we treat them all the same way.

Treating people with depression often begins with prescribing them an antidepressant. If one doesnt work, a second antidepressant is prescribed. Each of these trials often takes at least eight weeks to assess whether the drug worked and symptoms are alleviated.

If an antidepressant doesnt work, other treatments, such as psychotherapy or occasionally transcranial magnetic stimulation, may work. Often, doctors combine multiple treatments, Etkin says, but figuring out which combination works can take a while.

People often feel a lot of dejection each time a treatment doesnt work, creating more self-doubt for those whose primary symptom is most often self-doubt, Trivedi says.

The EMBARC trial enrolled 309 people with depression who randomly received either sertraline or a placebo.

For their study, Etkin and his colleagues set out to find a brain-wave pattern to help predict which depressed participants would respond to sertraline. First, the researchers collected EEG data on the participants before they received any drug treatment. The goal was to obtain a baseline measure of brain-wave patterns.

Next, using insights from neuroscience and bioengineering, the investigators analyzed the EEG using a novel artificial intelligence technique they developed and identified signatures in the data that predicted which participants would respond to treatment based on their individual EEG scans.

The researchers found that this technique reliably predicted which of the patients did, in fact, respond to sertraline and which responded to placebo. They replicated the results at four different clinical sites.

Further research suggests that participants who researchers predicted would show little improvement with sertraline were more likely to respond to treatment involving transcranial magnetic stimulation, or TMS, in combination with psychotherapy.

Using this method, we can characterize something about an individual persons brain, Etkin says. Its a method that can work across different types of EEG equipment, and thus more apt to reach the clinic.

Part of getting these study results used in clinical care is, I think, that society has to demand it, Trivedi says. That is the way things get put into practice. I dont see a downside to putting this into clinical use soon.

When researchers launched EMBARC, it was part of a broader effort by the NIMH to push for improvements in mental health care by using advances in fields such as genetics, neuroscience, and biotechnology, says Thomas Insel, who served as director of that institute from 2002 to 2015.

We went into EMBARC saying anything is possible, Insel says. Lets see if we can come up with clinically actionable techniques. He didnt think it would take this long, but he remains optimistic.

I think this study is a particularly interesting application of EMBARC, he says. It leverages the power of modern data science to predict at the individual level who is likely to respond to an antidepressant.

In addition to improving care, the researchers say they see a possible side benefit to the use of biologically based approaches: It could reduce the stigma associated with depression and other mental health disorders that prevents many people from seeking appropriate medical care.

Id love to think scientific evidence will help to counteract this stigma, but it hasnt so far, says Insel. Its been over 160 years since Abraham Lincoln says that melancholy is a misfortune, not a fault. We still have a long way to go before most people will understand that depression is not someones fault. (President Lincoln suffered bouts of depression.)

A paper on the work appears in Nature Biotechnology. Additional researchers from South China University of Technology, the Netherlands Research Institute, Harvard Medical School, the New York State Psychiatric Institute, Columbia University, and the Netherlands neuroCare Group contributed to the work.

Etkin is on leave from Stanford, working as the founder and CEO of the startup Alto Neuroscience, a company based in Los Altos, California that aims to build on these findings and develop a new generation of biologically based diagnostic tests to personalize mental health treatments with a high degree of clinical utility. Insel is an investor in Alto Neuroscience.

Funding came from the National Institutes of Health, the Stanford Neurosciences Institute, the Hersh Foundation, the National Key Research and Development Plan of China, and the National Natural Science Foundation of China.

Source: Stanford University

Read the original post:
Brain waves show who'll respond to Zoloft - Futurity: Research News

What will the US’s first weed degree program look like? – Big Think

Weed can now get you a degree. A public university in southern Colorado has announced that it will offer the United State's first cannabis-focused major.

The new Cannabis Biology and Chemistry Program was created after students at Colorado State University-Pueblo expressed intense interest in the field. The "rigorous" science degree will include coursework focused on chemistry and advanced biology according to David Lehmpuhl, dean of CSU-Pueblo's College of Science and Mathematics. In other words, it isn't going to be a chill party degree. He emphasized that students in the CBC program won't be working with anything that has a high amount of THC, the main psychoactive compound in weed.

The Colorado Commission on Higher Education passed the university's request for a cannabis-related degree earlier this month. Ever since, Lehmpuhl told WBUR the response has been "overwhelming."

"I've been fielding inquiries almost nonstop since the announcement came out," he said. "There's definitely a demand."

The ban on weed, which was outlawed in the 1930s, has only recently started to lift. Though it's still federally illegal, cannabis is now recreationally legal in 11 states plus Washington, D.C. It's legal for medical usage in 33 states. As a result, cannabis has become one of the fastest-growing job markets. Forbes has estimated that the industry is responsible for the employment of around 300,000 full-time workers.

"We kind of looked at the industry, and the sector as a whole, and what was needed for students to get jobs," said Lehmpuhl to Quartz. "We have a lot of businesses in the area that are clamoring for workers." In fact, CSU-Pueblo is also home to the state-funded Institute for Cannabis Research.

The new degree is intended to prepare students for opportunities to work in chemistry, biology or natural products labs. That could mean jobs ranging from CBD extraction to analyzing soil chemistry.

There's a cluster of U.S. schools that offer similar courses, certificates and master's degrees in cannabis-centric studies for students looking to pursue the up-and-coming industry. Northern Michigan University, for instance, offers a degree in Medicinal Plant Chemistry with a capstone course named CH420. (Haha.) What's unique about CSU-Pueblo is that it is the first undergraduate program in the country to put the word cannabis in its name, which has resulted in media attention and a flood of inquiries from prospective students according to Lehmpuhl.

The major will offer two tracks students can choose to take. One is "natural products," which places more emphasis on biological aspects of weed. The "analytical" track focuses on chemistry. The program overview states that through the degree, "students will understand cannabis physiology and growth, the pharmaceutical implications, and the practical applications for the industry."

The CBC program will officially start in the fall semester of 2020 with courses that include Cannabis Physiology and Growth, Medicinal Chemistry and Pharmacology, Medicinal Plant Biochemistry and Natural Products Extraction and Analysis. You can check out the program's full curriculum here.

Go here to read the rest:
What will the US's first weed degree program look like? - Big Think

Early history of Blacks, medicine in U.S. – pridepublishinggroup.com

Glenn Ellis

(TriceEdneyWire.com) From the time that Africans were enslaved on the west coast of Africa and packed onto ships for the horrific voyage across the Middle Passage, we have been intrinsically tied to the growth and development of the field of medicine in America.

This troubled history began with the substandard medical attention provided on the ships by doctors, whos charge was to keep as many enslaved beings alive as possible, in order to ensure the traders would make as much from the auctions that awaited them.

These doctors embraced their role, seeing it as an opportunity to enhance their reputations, as well as to improve their experience and practice dealing with a myriad of health issues within a captive patient base.

Once sold, and finding homes on plantations in this strange land, the inferior medical care continued. After all, there was an unlimited supply of human cargo headed, continuously, to Americas shores.

On the plantations in the South, doctors were few and far between. Their range of care was dependent upon their individual, professional training. Due to the shortage of doctors, the enslaved Africans were often left on their own to treat illnesses, handle medical emergencies, and to bring new life into this world. Many of these Africans continued to use traditional homemade remedies, folk beliefs, conjuring, and superstition to help meet their medical needs.

The shortage of doctors during this time was made worse by the fact that the Old South had only five medical colleges before 1845, and medical students spent only one to two years working with a preceptor and attended only a few lecture courses to complete their medical training.

In fact, due to the large numbers of enslaved Africans across the South, plantations provided a training ground for medical schools, students, and doctors. Many learned human anatomy through some of the most inhuman means, since people of African descent were thought by Whites to be different in the physiology and medical needs. There was also an opportunity to conduct medical research, and to develop, and perfect, many medical proceduressome of which are still in common use in medicine today.

Professor Ran Hogarth calls this medicalizing Blackness from her book of the same name). A few of the most notorious examples of this are:

Southern physician Dr. Samuel Cartwright, who believed that the size of Black peoples brains was a ninth or tenth less than in other races of men, while Black peoples hearing, sight, and sense of smell were better. This medicalization of Blackness wasnt removed from the medical manual for psychiatric diagnosis until the 1970s.

Dr. Cartwright also is responsible for another instance of medicalizing Blackness. He coined the term Drapetomania (with Greek roots roughly translating to runaway slave and crazy) as a disease that causes slaves to run away. Dr. Cartwright outlined a treatment for this disease. He reassured slave owners that it was entirely curable by whipping the devil out of the slaves who suffered from it!

From these we know that Dr. Cartwright was among the first respected doctors throughout the country who saw being Black and enslaved (and wanting to be free) was a psychological disorder.

Just as heinous as Dr. Cartwrights assertion was the work of Dr. J. Marion Sims, who is considered the Father of Gynecology. Vesico-vaginal fistula (VVF) results in a tear from the bladder to the vagina, in pregnant women during a difficult labor. Dr. Sims is credited for perfecting the procedure to successfully treat VVF, to the relief and benefit of millions of (mostly White) women all over the world. Prior to Sims contribution to the field of gynecology, women in Europe and the United States who suffered with VVF became social outcasts rejected from societygreat advancement for medicine, right?

The problem is, Dr. Sims conducted the development and testing of this revolutionary procedure on enslaved African women. In order to conduct research, Sims also needed to learn and understand as much as possible about the little-known anatomy of a womans reproductive system. He also needed to carry out countless attempts to perfect the procedures and develop the right instruments. He did this all successfully, with one exception: Dr. Sims did these extensively invasive, surgical procedures, often without any anesthesia!

Probably, the brightest ray of hope began to shine for enslaved Africans, as it related to medical care, came around, and after, emancipation. This represented the period of the rise of Black hospitals and medical schools, beginning with Freedmans Hospital in 1862 in Washington, D.C.

However, this was not to signal a permanent change for the better for Black health in the United States.

By 1920, there were over 200 Black hospitals, staffed by Black doctors and staff.

By some counts, this number reached almost 500 across the nation. But between 1961 and 1988, 50 closed, and another couple of dozen merged. Today, there is only one Black hospital: Howard University Hospital. And it is being managed by a Hedge Fund with a horrible record for running hospitals. One of their flagship hospitals, Hahnemann Hospital in Philadelphia closed last year as a result of poor management.

African Americans remain the least healthy ethnic group in the U.S.A., a somber legacy of years of racial and social injustice. As we continue to celebrate our history and our heritage, lets be mindful of the history of institutional racism in medicine.

Remember, Im not a doctor. I just sound like one. Take good care of yourselves and live the best life possible.

The information included in this column is for educational purposes only. It is not intended nor implied to be a substitute for professional medical advice.

(Glenn Ellis, is Research Bioethics Fellow at Harvard Medical School and author of Which Doctor?, and Information is the Best Medicine. Ellis is an active media contributor on Health Equity and Medical Ethics. For more good health information visit ).

Go here to read the rest:
Early history of Blacks, medicine in U.S. - pridepublishinggroup.com

‘It was impossible that I was having a heart attack’: Why Canadian women’s heart health continues to suffer – OttawaMatters.com

Helen Robert was getting ready to walk her dog one Friday morning in May 2015 when an abrupt feeling of dizziness washed over her. When she began to feel light-headed, the 54-year-old called her husband to ask him to re-schedule an appointment at the car dealership she had booked that day.

I was just talking to him and I started getting chest pains and it got more and more intense by the second, Robert said. I cant even describe the level of pressure I felt it was nothing Ive ever felt before.

Worried, she mentioned what she was feeling to her husband.

He was like, Do you think maybe youre having a heart attack? And I said, Thats just ridiculous.

But the feeling kept getting worse.

He said, I need you to hang up and I need you to call 9-1-1. Robert recalled. So, I did, but only begrudgingly because it was impossible that I was having a heart attack.

When paramedics arrived, they hooked Robert up to an ECG. When the test confirmed her heart was in distress, they rushed her to the emergency room.

I went up to ICU for about a day or so, she said. Things started to resolve itself. The chest pain went down but my heart was still in trouble. [Doctors] werent sure what to do with me because it seemed like I had had a heart attack but then it was sort of over.

It wasnt until five days later when Robert visited the University of Ottawa Heart Institute and an angiogram confirmed her fears: Robert an otherwise healthy woman had suffered a SCAD, also known as a spontaneous coronary artery dissection. Essentially, there was a tear in an artery wall and it was blockingthe blood flow to herheart.

Roberts story is all too common and its because women have largely been ignored in heart health research, B.C.-based cardiologist Dr. Jacqueline Saw says.

Generally, in North America and most developed countries, most of the studies that looked at heart disease primarily involved male subjects and women are typically (only) included in less than 30 per cent of the population being studied in these studies, she said. This unfortunately limits our ability to understand the comparative differences between men and women.

What makes men and women different is rooted in their physiology.

According to the Heart and Stroke Foundation, womens hearts and arteries are smaller, and plaque tends to build in different ways and the symptoms women experience during a heart attack and mini stroke are not the same as men.

For example, while both men and women can experience chest pain during a heart attack, women may not alwaysand are more likely to experience other less commons symptoms like shortness of breath, nausea, vomiting or arm, back or jaw pain.

Hormones and life events unique to women are also thought to play a role. While women tend to have a lower risk of heart disease prior to menopause because of the presence of estrogen, their risk increases with diabetes and pregnancy. Menopausal women are also at a heightened risk with the development of high cholesterol and high triglyceride levels.

And these shortfalls in research and understanding in medicine are hurting women.

Statistics show that 45 per cent more women than men died of a stroke in Canada last year.

When it comes to SCAD specifically, 90 per cent of cases are women, mostly between the ages of 30 and 60. What causes a SCAD to happen is still unknown, but its believed to start with the artery wall weakening.

While researchers and doctors still have a long way to go in understanding womens heart health, progress is being made, Saw says.

Weve certainly come along way in terms of raising awareness in the general public, Saw said. Gradually, were seeing more research funds that are directed towards looking at and addressing women with heart disease, and that certainly helps in terms of our quest for knowledge to understand more these conditions and how to manage them.

The areas that still need work, Saw says, are with prevention, diagnosis and treatment specifically with understanding what medications work best, as mens heart attacks tend to be more cholesterol-based rather than hormonal, as can bethe case for some women.

While Robert has recovered from her SCAD, she remains cautious thats because theres still a 20 per cent chance she may experience a second SCAD event.

To avoid another episode, Robert has had to make a few life changes, likeavoiding lifting heavy weights and keeping an eye on her stress levels.

Its really made me think about whats important and made me realize that tomorrow really isnt a guarantee, she said. So, I think a lot of things I was putting off until retirement, Im not procrastination as much anymore. If I get an opportunity to do something, I do it.

Five years later as Robert looks back on what shes been through, she says the experience has been surreal.

What Ive learned since is just that we as women need to pay attention to our bodies, she said. We need to recognize that we really are only human and we can only handle so much. If nothing else, this experience has kind of given me the strength to realize that a lot of things I used to think were important are really not that important anymore.

Its been a time of reflection and really sorting out what is important for me and learning to appreciate the things that I have, she added.

And part of her new outlook on life includes helping other women byraising awareness through the Heart and Stroke Foundation and the University of Ottawa Heart Institute.

I just want to raise awareness to other women who might not realize that it is possible to have a heart attack, regardless of what they do, she said.

Robert hopes more women will talk to their doctors about any symptoms or concerns they have about their heart health, as well as consider participating in research.

Read more here:
'It was impossible that I was having a heart attack': Why Canadian women's heart health continues to suffer - OttawaMatters.com

Basic Immunology | The IBD Immunologist

The immune system, defined in the simplest terms, is the system in our bodies that defends us against infectious disease. However, our immune systems are far more complex. Not only does it defend us against pathogens, it is also responsible for protecting us against cancer, initiating allergy symptoms, and determining the state of our general health.

The Immune system itself is like a miniature world in our bodies, and it is populated with various immune cells that are supported by the cells making up the tissues and organs of the body. Each type of immune cell has its own specialized function. Some are good at fighting infectious bodies hand to hand like soldiers, while others are specialized at scouting, intelligence and recruitingother cell types during battle. During an immune response, the cells of the surrounding tissues also play their roles and, much like civilians in war, they fight, warn others, or die as a result of the battles.

I will do my best to introduce you to this exciting world in simple terms.

To put it quite simply, the Immune System is designed to protect you. Immunologist refer to the body often as self. This includes all the products of the body ranging from your tissues to the smallest secreted molecules. Life forms and molecules that interact with your body are considered non-self. The non-self life forms are parasites, bacteria and viruses as well as friendly intestinal bacteria. Common non-self molecules that we often encounter are food, pollen and chemical substances from our environments (like drugs, cleaning products and hygienic products)1.

Cells of the immune system are born from hematopoietic stem cells found deep in the bone marrow. Hematopoietic stem cells are immortal, capable of generating daughter cells, called progenitors that will later give rise to different type of immune cells. There are two main types of progenitors created, the myeloid progenitors and the lymphoid progenitors2.

Cells of Myeloid Progenitors

For immunologists, the mammalian body is divided into three main regions: the primary lymphoid areas, the secondary lymphoid areas and the periphery.

The primary lymphoid areas include the bone marrow and the thymus. The bone marrow, as we mentioned, is the site of immune cell generation2. The thymus, on the other hand, is the location of T cell development4. Lymphoid progenitor populations travel there from the bone marrow and produce a population of immature thymocytes. It is these thymocytes that give rise to the varied T cell populations.

The secondary lymphoid areas include the adenoids, tonsils, spleen, lymph nodes and lymphoid follicles found in the gastrointestinal system and the mucosa (areas adjacent to a mucus membrane). These areas house lymphocytes and support the development of an adaptive immune responses5-7.

The periphery includes all regions that are not included in the primary and secondary lymphoid areas. This includes areas like the skin, brain, joints, muscles and gastrointestinal/mucosal areas surrounding lymphoid follicles.

In order for an immune response to be initiated, there must be some kind of danger. This is a fairly simple idea, but it leads to the question: How is danger defined by the immune system? This question is actually one of the most exciting topics of immunology today. Simply put, danger is sensed by the immune system through two main avenues: the recognition of a pathogen-associated molecular pattern (PAMP)8 or through the release of cell molecules associated with trauma which are called danger-associated molecular patterns (DAMPs) or alarmins9. Examples of PAMPs would be cell wall lipoproteins of bacteria and an example of DAMPs would be ATP (adenosine triphosphate), a nucleotide used as an energy source in cells10.

PAMPs and DAMPs are recognized by the cells of the immune system and non-immune cells, through receptors located at the cell surface or internally8,9. PAMPs are also recognized by several non-cellular systems as well11,12. This recognition initiates the very first processes of an immune response called the innate immune response.

Immune cells, non-immune cells and non-cellular systems all participate in initiating an innate immune response. Why is it called innate? Its innate because it depends on intrinsic systems that are built into your body to recognize danger and there is no learning or adaptation involved.

In order to detect PAMPs or DAMPs, cells need tools to recognize them. These tools are protein receptors that can be found on the cell surface as well as internally. In general, they are called pattern recognition receptors or PRRs. These receptors come in families consisting of multiple members. Receptors that recognize PAMPs include the Toll-like receptors (TLRs), the C-type lectin receptors (CLRs), the NOD-like receptors (NLRs), RIG-I-like receptors (RLRs)8 and invariant T cell receptors13,14.

DAMP receptors are not so clear-cut. TLRs have been implicated15 as well as the receptor for advanced glycation endproducts (RAGE)15. Also the purinergic receptors that recognize ATP would also fall into this category10.

These receptors are found on most cells of the body. They recognize a variety patterns associated with a number of pathogens including virus-associated nucleic acids; bacterial-associated cell wall components, protein, ribosomal RNA and DNA; and protozoan-associated proteins8. The majority is found extracellularly, but a number are also found intracellularly. When stimulated they activate the transcription factor NFB, which is essential for activating a cells immune functions and set off a signal cascade via MAP kinase (a phosphorylating enzyme)8.

These receptors are specialized in recognizing carbohydrate structures, such as the sugar mannose, which is a common component of fungal cell walls16. Thus, these receptors are found on the cell surface. Though much of the literature involves their expression on immune cells, reports of CLR variants on non-immune cells can also be found17. On the phagocytic cells, it is known that they can participate in endocytosis, the engulfment of particles or pathogens and respiratory burst16. Some also appear to initiate signal cascades similar to TLRs leading to NFB and MAP kinase activation, but it also appears that they can work in concert with TLRs, enhancing or inhibiting their function16.

These receptors are found in the cytoplasm of cells. Traces of their expression is found in most organs of the body18 and it is probably safe to say that most immune cells express at least some members of the NLR family. These receptors are designed to detect intracellular bacteria and, possibly, endogenous stress molecules and allow the cell to produce one of the most potent inflammatory mediators, Interleukin (IL)-119.

Like NLRs, RLRs are also found in the cytoplasm of a cell. Instead of detecting bacterial products, these receptors help detect viral infection20. They do this by binding to RNA produced during viral replication. Working together with nucleic-acid detecting TLRs, they lead to NFB, MAP kinase activation and activation of Interferon regulatory factor (IRF) transcription factors20. The IRF transcription factors are necessary to produce cytokines specialized for the control of viral infections. Cytokines are small, secreted proteins used as messengers between cells, which alert surrounding immune cells about danger.

Areas of the body that come in contact with the outside world (skin, gastrointestinal and mucosal areas) are covered with an epithelial layer. Epithelial layers are composed mainly of cells called epithelial cells. These cells form an anatomical barrier and they have their own immune functions. When exposed to DAMPs or PAMPs, epithelial cells produce inflammatory cytokines 21. The cells of the epithelial layer are often the main cells involved in the first detection of pathogens and/or danger. The majority of cells in the body also have this capacity. Other cell types like muscle cells, adipocytes and fibroblasts are all outfitted with receptors to detect PAMPs and DAMPs8,22. Just like citizens of a city, they will alert the authorities if there are any problems.

Under epithelial layers are resident macrophages, neutrophils, dendritic cells, NK cells, mast cells and a number of T cell-related cells.

The name macrophage is derived from Greek, meaning large eaters. Their main function is to phagocytize (engulf) pathogens and particles. It does this by wrapping its plasma membrane around particles until they are enveloped and pinched off to form an endosome inside the cell. Once inside the cell, the endosome merges with a lysosome that contains enzymes and acids that can digest the contents. Macrophages also have the ability to generate a respiratory burst, which is a release of oxygen radicals that damage surrounding pathogens and cells. They also can alert and attract other immune cells through inflammatory cytokine release23.

Neutrophils are the main foot soldiers of the innate immune response and are certainly the most abundant. They also have a wide arsenal of tools to deal with invaders. Like macrophages, neutrophils can phagocytize particles, release a respiratory burst and produce inflammatory cytokines. Unlike macrophages, neutrophils have the internal caches of anti-microbial substances called granules24.

Dendritic cells are also phagocytic cells, but they have the special ability of initiating an adaptive immune response (will be discussed later). Unlike neutrophils and macrophages, Dendritic cells or DCs are not simple foot soldiers. Instead, they function more as spies and provide intelligence about invaders to T cells through a phenomenon called antigen presentation and through cytokine production25.

The NK stands for Natural Killer and the name implies their function. These cells, however, do not kill pathogens directly. Instead, these cells have the ability to recognize when other cells are harboring internal pathogens using special receptors and then kill them. Situations where this might occur is during viral and mycobacterial infections. These pathogens easily reside in host cells, finding ways to block lysosome fusion and their own destruction26.

Mast cells are the cells that are responsible for the classic signs of inflammation, which include redness, swelling and heat. Though well known for their association with allergy, they also can detect PAMPs and DAMPs through receptors and become immunologically active. Mast cells exert their functions mainly through cytokine and granule release. Unlike neutrophils, which release antimicrobial substances, mast cells release histamine and heparin. Histamine is well known for its vasodilator function and ability to allow fluid to leak between cells, causing redness and swelling. It also causes inflammatory itching by triggering neurons (unmyelinated C-fibers) responsible for the itch feeling. Heparin prevents blood coagulation27.

Most T cells are part of the adaptive immune response as they have adaptive T cell receptors (receptors that learn to recognize pathogens). NK T cells and T cells, however, use invariant T cell receptors (receptors that do not rearrange) or semi-invariant T cell receptors and participate in the innate immune response.

NK T cells are similar to the NK cells mentioned above. Not so much in function, but more in how they look. These cells share many of the same surface protein markers. NK T cells, however, do not kill compromised cells. Instead, they are quick cytokine producers. In doing so, they quickly notify all surrounding cells that there is problem when they recognize PAMPs presented to them via dendritic cells28.

The T cells are important for innate immune reactions and the adaptive immune response as they have invariant and variant T cell receptors. Their precise function remains unclear, but they can secrete cytokines and, like the NK T cells above, participate in alerting and strengthening local immune responses29.

Besides cells, there are also defenses in your body that are ready to react to pathogens as soon as they are encountered, much like booby traps. These systems rely on small proteins that are found within the bodily fluids.

The liver synthesizes the proteins of the complement system and they work in concert to aid in phagocytosis, bacteria lysing and immune cell attraction. One can visualize it as a self-assembling machine that starts to assemble as soon as the first proteins are bound and in place. The complement machine is known to be initiated by three different pathways: the classical pathway, the alternative pathway and the lectin pathway. The classical pathway is triggered when antibodies are bound to a pathogen. The alternative pathway is triggered when the victim is unable to block the cascade (normal cells can, while pathogens cannot). The lectin pathway uses free lectin proteins (lectins are proteins that bind sugars) to bind sugars associated with bacterial cell walls)11.

These proteins are also produced by the liver and especially during inflammation when pro-inflammatory cytokines are produced. Many are designed to coat pathogens and have chemotactic properties (have the ability to attract cells). Some inhibit microbial growth by sequestering iron from the environment. The lectins from the lectin pathway of complement activation are considered acute phase proteins30.

Often called defensins, these peptides function as natural antibiotics and our produced by cells that guard the external surfaces and internal surfaces such as the skin and the gastrointestinal system. In the skin, the main sources are keratinocytes, mast cells, neutrophils, sebocytes and eccine epithelial cells. In the intestines, one of the main producers are the Paneth cells of intestinal crypts31.

The adaptive immune response is what gives individuals long-term immunity to a pathogen after vaccination. Instead of relying on germ-line encoded receptors for the recognition of pathogens like the innate immune system, it depends on the development of receptors that can recognize any unique molecular characteristic of pathogens32. The molecules that can be recognized are called antigens. The classical definition of an antigen is any molecule that can provoke the development of antibodies. A better, and less-confusing, definition is a molecule that can be recognized by the adaptive immune system. The molecules are often protein peptides (small pieces of protein). But, they can also be sugars, lipids and other small molecules under the right circumstances. The main players of the adaptive immune response are the T cells (both T helper cells and cytotoxic T cells) and the B cells.

During the innate immune response, the first steps are taken to initiate an adaptive immune response. The main cells responsible for this step are the DCs that we described earlier25. As we mentioned before, DCs are a phagocytic cell type. This means that they have the ability to engulf pathogens/particles in endosomes and later fuse these vesicles to lysosomes for destruction. The process, however, does not stop here. Instead of just disposing of the pathogen/particle waste, the DC, instead, uses these parts to educate T helper cells about the pathogens. It does this by traveling from the location where it picked up its parcel to the local lymph node, where it finds T helper cells. Once there, it presents the pathogen-associated peptides on its surface using molecules called MHC class II molecules and provides information to T cells about how it should respond using surface molecules called co-stimulatory molecules and cytokines. Educating T helper cells is the first step towards initiating an adaptive immune response.

T helper cells or Th cells are crucial cells in the adaptive immune response and they are characterized by a surface protein called, CD4. They hold the key to initiating the functions of cytotoxic T cells33 and B cells34. Furthermore, they can also increase the efficacy of macrophages23.

Th cells interact with the MHC class II/peptide complexes presented by antigen presenting cells through its receptor, called the T cell receptor (TCR). If a T cell has never before seen antigen, it is called a nave T cell. In this situation, the T cell will need instruction from a professional antigen presenting cells, usually a DC, about how to perform its function. DCs do this through cell surface proteins call co-stimulatory molecules and through cytokine expression. This process is consists of three main signals. The first signal is the antigen recognition; the second signal is co-stimulation and the third cytokine exposure. This whole process is referred to as priming of the nave T cell. Once primed, the T cells begin to divide; a process that is referred to as expansion or proliferation35.

The most important set of co-stimulatory molecules is CD80 or CD86 on the DC and CD28 on the T cells. This second signal is necessary to tell the Th cell that there is a problem. If signal one is given without this second signal, the T cell will assume that the antigen is actually harmless and become non-responsive in a process called anergy36. Only a DC that has encountered a PAMP or another danger signal will express CD80 or CD86 on its surface reassuring the Th cell that there is, indeed, a problem.

Signal three is the secretion of cytokines of the DC. There are several cytokines important for Th cell eduction. They most important ones are IL-4, IL-12, IL-6, TGF and IL-10. Th cells will differentiate into different types of Th cells depending on which cytokines prevail. The main types of Th cells are T helper 1 (Th1) cells, T helper 2 (Th2) cells, T helper 17 (Th17) cells, and induced regulatory T cells (iTreg)35.

Each Th cell subtype has its own unique set of skills. One could almost see differentiation as an occupation. Just like an athlete will choose to develop her body and a scientist will choose to develop her mind. In humans, these choices are reflected at the level of gene transcription and protein expression. The athlete will stimulate muscle growth and the scientist develops the cerebral cortex of the brain. Its the same for Th cell differentiation. The four main subtypes of Th cells are listed. There are, however, rare forms that have been observed that are not listed and Th cells, much like humans, can fall into gray areas between the stereotypes.

The Th1 path is chosen when T cells are exposed to IL-12 during priming. Th1 cells are characterized by the production of the cytokine, interferon- (IFN) and the expression of the master transcription factor, T-bet. Th1 cells are experts at gearing the immune response towards to the control of internal pathogens like viruses and mycobacteria, which reside internally in macrophages. They perform this function by initiating cytotoxic T cell responses, helping macrophages to become more effective, by helping B cells to produce certain types of antibodies. These functions are executed, in part, through IFN exposure, however, some require cell-cell contact and will be explained in more detail later37.

Th2 cells are created during exposure to high amounts of IL-4. This leads to the expression of the Th2-associated master transcription factor, GATA3. Th2 cells are also characterized by the production of IL-4 (indeed, the same cytokine needed to create them). These cells are designed to skew the immune system towards a humoral immune response (antibody response) that can deal with parasite infection. Unfortunately, Th2 responses are also the ones associated with allergy development as well. Th2 cells do their work by effectively helping B cells and encouraging specific forms of antibodies. This is done through a combination of IL-4 exposure and cell-cell interactions37.

The Th17 subtype is the most recently described of the Th subtypes. It is most effective at controlling extracellular bacterial and fungi responses, like those found during intestinal food poisoning or during a yeast infection. Its creation is dictated by the cytokines IL-6 and TGF and this leads to the expression of the master transcription factor, RORt. Th17 cells produce the cytokine IL-17. IL-17 production is one of the main facilitators of their function and it encourages surrounding cells to increase neutrophil migration. Neutrophils are excellent phagocytic cells with many bacterial killing tools38.

To those just learning about the immune system, the existence of the following Th subtype may be confusing. iTreg are designed to counter the functions of other immune cells. Why? The reason is that immune responses are highly damaging to surrounding tissues and, without them, immune responses would spiral out of control.

That said; these cells are induced by DCs when they are exposed to high amounts of IL-10 or TGF. This causes the expression of the master transcription factor, Foxp3. In turn, iTreg produce IL-10 or TGF. IL-10 and TGF are what is called anti-inflammatory cytokines. They have the ability to limit the functions of immune cells. IL-10, for instance, lowers Th1 and Th17 responses and reduces macrophage efficacy. TGF encourages apoptosis (induced death of cells), prevents cell division and lowers phagocytosis39.

Th cells are not the only kind of T cell. Cytotoxic T cells (CTLs), characterized by the surface marker CD8, are not to be missed and are essential for the elimination of viral infections. The function of a CTL is found in its name. Cyto refers to cell and toxic means just how it sounds. These cells are cell toxic and kill other cells. In many ways, they are similar to the NK cells and NK T cells of the innate immune system. However, they do not use invariant receptors to recognize problems in other cells, but instead use an adaptive system.

CTLs, like Th cells, have a TCR. This means that they can detect unique peptides presented to them by other cells. In the case of Th cells, these are MHC class II molecules presented via DCs. In the case of CTLs, they are MHC class I molecules. During an infection, as we earlier mentioned, DCs will travel to the lymph node and present samples of the intruder to the T cells. This is also happens for CTLs. However, despite the presence of all the priming signals, priming will be suboptimal. CTLs need an additional signal, jokingly called the license to kill. This signal is given by a Th1 cell through the production of a cytokine called IL-2, which stimulates CTL expansion; and through an interaction between the Th1 cell and the DC via CD40 on the DC and CD40 ligand on the Th1 cell, which makes the DC more effective at priming CTLs33. Once a CTL is primed and active, it has the ability to kill.

As you can see, CTL activity is highly controlled to ensure that they react only to pathogen-associated peptides. The reason is that MHC class I can be expressed by every cell type in the body. MHC class I on a cell is like a sign advertising the health of the cell. The cell is constantly displaying samples of the proteins its making. If an active CTL recognizes one of these samples as being of viral origin, it kills that cell; eliminating a viral host.

The word humor means fluid in Latin and, therefore, humoral immune responses relate to non-cellular systems found in the bodily fluids. Weve already discussed non-cellular components of the innate immunity, however, in immunology most people are not referring to these non-cellular systems when they use the term humoral immune response. Instead, they are referring to the immune response mediated by antibodies and this is part of the adaptive immune response.

The cell behind antibody responses is the B cell. Nave B cells of the immune system produce rudimentary antibodies (see below) until other cells activate them. B cells, unlike the T cells, are not required to interact with DCs; instead B cells reside in lymphoid tissues and fish for antigens that they recognize using their B cell receptors or BCR. The BCR looks like a surface bound antibody and once it binds a molecule, the B cell engulfs it and much like the phagocytes, digests it. Just like the DC, the B cell will then present pieces of the antigen to Th cells using MHC class II molecules. Primed and activated Th cells, which recognize the presented peptides, are then able to help the B cell through a CD40-CD40 ligand interaction. The Th cell also provides cytokine signals to tell the B cell which kinds of antibodies it should make34.

This process is reminiscent of the priming process of Th cells. Signal one is the MHC class II/peptide and TCR interaction between the B cell and the T cell. Signal two is the costimulatory help provided by the T cell in the form of CD40-CD40 ligand interactions. And, signal three is the cytokine message provided by the T cell.

Helped B cells will then further differentiates into plasma cells, which can produce massive quantities of antibodies.

Antibodies, by themselves, cause very little harm. However, their strength lies in their ability to tag a molecule as harmful and block molecular functions. Antibodies enhance the functions of the innate immune system. They can bind to pathogens and particles to initiate the complement system and induce phagocytosis. They can also block/neutralize molecular interactions. Examples of this function would be an antibody that blocks the toxic effects of diphtheria toxin or antibodies the block viral binding sites to cells. Antibodies also interact directly with cells and can change their function by binding to specific antibody receptors found on the surfaces of immune cells40.

An Antibody is a small protein structure produced by B cells. It is also called an immunoglobulin (Ig). It looks like a Y and it is formed from four separate proteins. Each tip of the Y recognizes and sticks to the antigen, meaning that each antibody can bind two similar antigens. A single arm is called a Fab (Fragment, antigen binding) fragment. The base of the Y is called the Fc (Fragment constant) region and, while the Fab fragments dictate the specificity of the antigen binding, the Fc region dictates the type of antibody or isotype. The antibody isotype is dictated by the prevalent cytokines in the environment as well as additional danger signals that the B cell experienced while being helped by the Th cell41.

The first types of antibodies that a B cell can produce are IgM and IgD. The M and D refers to different classes of the Fc region. IgM is found as a pentamer, with five individual IgM antibodies bound by their Fc regions in the center forming a star. They are effective at complement activation. IgD is found as a monomer and its function is undefined. However, it has the ability to bind mast cells via an Fc receptor ( for D) and induce anti-microbial peptide secretion.

IgG antibodies are found as monomers and they are very potent at stimulating immune responses. They are capable of neutralization, inducing phagocytosis in macrophages and neutrophils via Fc receptors ( for G), activation of complement, and also the activation of NK cells (also via Fc receptors).

IgE antibodies are monomers. They are known to cause mast cell degranulation via binding of Fc receptors ( for E). They are induced during parasite infection and, unfortunately, also during allergy.

IgA is found as a dimer of two antibodies attached via their Fc regions. It is involved with mucosal defense: found in gastrointestinal system, the respiratory systems. They are particularly effective at neutralization of microbes and toxins.

Once the adaptive immune system has formed a response, the body has a long-term record of the invading pathogen in the form of long-lived plasma cells, memory T cells (not covered here) and antibodies. This is why vaccination is so important. It allows your body to create an adaptive immune response against an invader without having to truly become infected42.

When a body encounters a pathogen for the second time, its a completely different situation than the first encounter. During a second infection, T cells drawn to the inflammation site will have knowledge to help macrophages, recruit more neutrophils, and kill infected cells. Antibodies will be now present to assist complement activation, the phagocytosis of particles, and even kill microbes. The response will be quicker and more effective.

Though separating the two types of responses: innate and adaptive, helps with learning; it can also become an obstacle to seeing the immune response as a complex, dynamic system. It is important when looking at an immunological problem to consider the hosts previous history as it has so much influence on the immune response.

It is my sincere wish that this basic immunology overview helps with your understanding of the immune system. Keep in mind, that it is simplistic (skipping whole areas of immunological interest at times) and I have avoided adding too much terminology. If there are aspects that are particularly confusing, dont hesitate to mention them and I will do my best to update this document.top

1. Tauber, A. I. A. The immune self: theory or metaphor? Immunol Today 15, 134136 (1994).

2. Baldridge, M. T., King, K. Y. & Goodell, M. A. Inflammatory signals regulate hematopoietic stem cells. Trends Immunol 32, 5765 (2011).

3. Wu, L. & Liu, Y.-J. Development of Dendritic-Cell Lineages. Immunity 26, 1010 (2007).

4. Anderson, G. & Takahama, Y. Thymic epithelial cells: working class heroes for T cell development and repertoire selection. Trends Immunol 33, 256263 (2012).

5. Girard, J.-P., Moussion, C. & Frster, R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 12, 762773 (2012).

6. Koboziev, I., Karlsson, F. & Grisham, M. B. Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation. Annals of the New York Academy of Sciences 1207 Suppl 1, E8693 (2010).

7. Mebius, R. E. & Kraal, G. Structure and function of the spleen. Nat Rev Immunol 5, 606616 (2005).

8. Takeuchi, O. & Akira, S. Pattern Recognition Receptors and Inflammation. Cell 140, 805820 (2010).

9. Hirsiger, S., Simmen, H.-P., Werner, C. M. L., Wanner, G. A. & Rittirsch, D. Danger Signals Activating the Immune Response after Trauma. Mediators Inflamm. 2012, 110 (2012).

10. Yao, Y., Levings, M. K. & Steiner, T. S. ATP conditions intestinal epithelial cells to an inflammatory state that promotes components of dendritic cell maturation. Eur. J. Immunol. (2012).doi:10.1002/eji.201142213

11. Fujita, T., Matsushita, M. & Endo, Y. The lectin-complement pathwayits role in innate immunity and evolution. Immunol Rev 198, 185202 (2004).

12. Tarr, A. W., Urbanowicz, R. A. & Ball, J. K. The Role of Humoral Innate Immunity in Hepatitis C Virus Infection. Viruses 4, 127 (2012).

13. Le Bourhis, L. et al. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 32, 212218 (2011).

14. Juno, J. A., Keynan, Y. & Fowke, K. R. Invariant NKT Cells: Regulation and Function during Viral Infection. PLoS Pathog 8, e1002838 (2012).

15. Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R. & Coyle, A. J. HMGB1 and RAGE in Inflammation and Cancer. Annu. Rev. Immunol. 28, 367388 (2010).

16. Hardison, S. E. & Brown, G. D. C-type lectin receptors orchestrate antifungal immunity. Nat Immunol 13, 817822 (2012).

17. Weng, L. et al. Isolation and characterization of chondrolectin (Chodl), a novel C-type lectin predominantly expressed in muscle cells. Gene 308, 2129 (2003).

18. Lech, M., Avila-Ferrufino, A., Skuginna, V., Susanti, H. E. & Anders, H. J. Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice. Int Immunol 22, 717728 (2010).

19. Rubino, S. J., Selvanantham, T., Girardin, S. E. & Philpott, D. J. Nod-like receptors in the control of intestinal inflammation. Current Opinion in Immunology 24, 398404 (2012).

20. Ireton, R. C. & Gale, M., Jr RIG-I Like Receptors in Antiviral Immunity and Therapeutic Applications. Viruses 3, 906919 (2011).

21. Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8, 411420 (2008).

22. Drouet, M., Dubuquoy, L., Desreumaux, P. & Bertin, B. Visceral fat and gut inflammation. Nutrition 28, 55 (2012).

23. Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11, 723737 (2011).

24. Nathan, C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6, 173182 (2006).

25. Coombes, J. L. & Powrie, F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 8, 435446 (2008).

26. Sun, J. C. & Lanier, L. L. NK cell development, homeostasis and function: parallels with CD8+ T cells. Nat Rev Immunol 11, 645657 (2011).

27. Abraham, S. N. & John, A. L. S. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10, 440452 (2010).

28. Godfrey, D. I., Stankovic, S. & Baxter, A. G. Raising the NKT cell family. Nat Immunol 11, 197206 (2010).

29. Kronenberg, M. & Havran, W. L. Frontline T cells: T cells and intraepithelial lymphocytes. Immunol Rev 215, 57 (2007).

30. Baumann, H. & Gauldie, J. The acute phase response. Immunol. Today 15, 7480 (1994).

31. Brogden, K. A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nature Publishing Group 3, 238250 (2005).

32. Boehm, T. Design principles of adaptive immune systems. Nat Rev Immunol 11, 307317 (2011).

33. Behrens, G. et al. Helper T cells, dendritic cells and CTL Immunity. Immunol Cell Biol 82, 8490 (2004).

34. Cerutti, A., Puga, I. & Cols, M. New helping friends for B cells. Eur. J. Immunol. 42, 19561968 (2012).

35. Wilson, C. B., Rowell, E. & Sekimata, M. Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 9, 91105 (2009).

Go here to read the rest:
Basic Immunology | The IBD Immunologist